1
/
of
0
FDA Drug Approval, A088587, HYDROCHLOROTHIAZIDE
FDA Drug Approval, A088587, HYDROCHLOROTHIAZIDE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
ANDA: 088587
Company: ROXANE
Drug Name: HYDROCHLOROTHIAZIDE
Active Ingredients: HYDROCHLOROTHIAZIDE
Strength: 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SOLUTION;ORAL
Action Date: 07/02/1984
Marketing Status: Discontinued
Submission Classification: ORIG-1 TE Code: None
Company: ROXANE
Drug Name: HYDROCHLOROTHIAZIDE
Active Ingredients: HYDROCHLOROTHIAZIDE
Strength: 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: SOLUTION;ORAL
Action Date: 07/02/1984
Marketing Status: Discontinued
Submission Classification: ORIG-1 TE Code: None
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details